Comprehensive collection of peer-reviewed research demonstrating the effectiveness of harm reduction strategies. These studies inform ADUA's mission and validate our blockchain-powered funding model.
1 study
3 studies
2 studies
1 study
1 study
1 study
1 study
1 study
Nafeh et al. (2025) • Harm Reduction Journal
Safer supply programs providing regulated pharmaceutical alternatives showed positive health outcomes including reduced non-fatal overdose risk and fewer emergency department visits among participants.
Vickers-Smith et al. (2025) • JAMA Network Open
Self-reported fentanyl test strip use among people who use drugs was significantly associated with lower odds of experiencing overdose. Users reported behavioral changes including using less, going slower, and using with others when fentanyl was detected.
Michigan Department of Health & Human Services (2025) • State Health Report
Following statewide expansion of harm reduction programs including naloxone distribution, syringe services, and peer support, Michigan saw overdose deaths decline from 2,931 in 2023 to a provisional 1,877 in 2025—a 36% reduction.
NYC Department of Health (2023) • NEJM Catalyst
New York City's first overdose prevention centers reported zero fatal overdoses among thousands of supervised consumption events in their first year of operation. Sites also provided 16,000+ referrals to treatment and social services.
Piatkowski et al. (2024) • International Journal of Drug Policy
Harm reduction programs led by people with lived experience of drug use showed higher engagement rates, reduced stigma, and better retention compared to traditional clinical models. Peer workers contributed through needle exchange, education, and community-based research.
Vital Strategies (2024) • Program Evaluation Report
Comprehensive evaluation of overdose prevention programs found that harm reduction initiatives including take-home naloxone distribution prevented more than 1,650 deaths in 2024. Programs distributed over 500,000 naloxone kits.
Tilhou et al. (2023) • Harm Reduction Journal
People who used fentanyl test strips and other drug checking services reported significant changes in consumption patterns when unexpected substances were detected, including discarding drugs, using smaller amounts, and ensuring others were present.
Garipy et al. (2025) • Systematic Review
Systematic review of six studies found that supervised consumption sites were associated with reduced overdose mortality within 500 meters of facility locations. Effects were strongest in areas with highest overdose rates.
Mammoliti et al. (2026) • Drug and Alcohol Review
Scoping review identified emergence of novel synthetic opioids more potent than fentanyl (nitazenes, isotonitazene) in Australian drug markets. Current harm reduction tools require adaptation for these substances.
Claborn et al. (2022) • Harm Reduction Journal
Development and pilot testing of digital platform for community overdose response showed promise for real-time alerts, virtual overdose prevention, and coordination among harm reduction organizations. Platform facilitated 2,400+ interventions.
Animal tranquilizer increasingly found in drug supply. Not reversed by naloxone and causes severe skin wounds. Researchers developing xylazine test strips and wound care protocols specific to this emerging threat.
Emergence of nitazenes, isotonitazene, and etonitazene—substances more potent than fentanyl. Current harm reduction tools require adaptation. Research focuses on detection methods and appropriate naloxone dosing.
Technology-enabled overdose prevention including virtual monitoring, "never use alone" hotlines, and community alert systems. COVID-19 pandemic accelerated adoption. Research evaluating effectiveness and scalability.
Integration of harm reduction principles into mainstream healthcare including emergency departments, primary care, and hospitals. Studies show low-threshold approaches increase treatment engagement without requiring abstinence.
ADUA's blockchain-powered funding model directs resources to evidence-based interventions with proven track records of saving lives.
Access comprehensive research summaries, policy briefs, and evidence reviews compiled by ADUA's research team.
50-page compilation of all studies cited on this page with full citations and abstracts.
Evidence-based policy recommendations for implementing safer supply programs.
When you hold ADUA tokens, you're not just investing in cryptocurrency—you're funding proven harm reduction interventions that save lives.